Basel Medical Group Ltd Ordinary Shares (United States) is listed on the Nasdaq and has a market capitalization of $8.31 million, with shareholders equity totaling $3.96 million.
The company employs approximately 82 people and operates in the Other sector, within the Others industry.
Over the past 12 months, Basel Medical Group Ltd Ordinary Shares reported $19.04 million in revenue, generating net income of $-4.59 million.
Key financial metrics include a P/E ratio of -1.81, a price-to-book (P/B) ratio of 2.10, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker BMGL.